Developments in pharmacological therapy for the overactive bladder

被引：9
作者：
Chapple, Christopher R.
Gormley, E. Ann
机构：
[1] Sheffield Hallam Univ, Dept Urol, Sheffield Teaching Hosp, NHS Fdn Trust, Sheffield 510 2JF, S Yorkshire, England
[2] Dartmouth Hitchcock Med Ctr, Sect Urol, Lebanon, NH USA
来源：
BJU INTERNATIONAL | 2006年 / 98卷
关键词：
overactive bladder; pharmacotherapy; detrusor overactivity; cholinergic-muscarinic receptors; adrenoceptor; agonist; antagonist; anticholinergics; vanilloids; botulinum toxin; RAT URINARY-BLADDER; QUALITY-OF-LIFE; DETRUSOR SMOOTH-MUSCLE; ANTIMUSCARINIC AGENT SOLIFENACIN; SELECTIVE RECEPTOR ANTAGONIST; EXTENDED-RELEASE FORMULATIONS; CARBACHOL-INDUCED CONTRACTION; BOTULINUM-TOXIN; CONTROLLED TRIAL; AUTONOMOUS ACTIVITY;
D O I：
10.1111/j.1464-410X.2006.06381.x
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：78 / 87
页数：10
相关论文
共 96 条
  • [81] Electrical characteristics of suburothelial cells isolated from the human bladder
    Sui, GP
    Wu, C
    Fry, CH
    [J]. JOURNAL OF UROLOGY, 2004, 171 (02) : 938 - 943
  • [82] Gap junctions and connexin expression in human suburothelial interstitial cells
    Sui, GP
    Rothery, S
    Dupont, E
    Fry, CH
    Severs, NJ
    [J]. BJU INTERNATIONAL, 2002, 90 (01) : 118 - 129
  • [83] THE VANILLOID (CAPSAICIN) RECEPTOR - RECEPTOR TYPES AND SPECIES-DIFFERENCES
    SZALLASI, A
    [J]. GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM, 1994, 25 (02): : 223 - 243
  • [84] Vanilloid receptors: New insights enhance potential as a therapeutic target
    Szallasi, A
    Blumberg, PM
    [J]. PAIN, 1996, 68 (2-3) : 195 - 208
  • [85] Urothelium derived inhibitory factor and cross-talk among receptors in the trigone of the bladder of the pig
    Templeman, L
    Chapple, CR
    Chess-Williams, R
    [J]. JOURNAL OF UROLOGY, 2002, 167 (02) : 742 - 745
  • [86] THE INFLUENCE OF BETA-ADRENOCEPTOR AND MUSCARINIC RECEPTOR AGONISTS AND ANTAGONISTS ON THE STATIC URETHRAL CLOSURE FUNCTION IN HEALTHY FEMALES
    THIND, P
    LOSE, G
    COLSTRUP, H
    ANDERSSON, KE
    [J]. SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 1993, 27 (01): : 31 - 38
  • [87] Effects of tolterodine, trospium chloride, and oxybutynin on the central nervous system
    Todorova, A
    Vonderheid-Guth, B
    Dimpfel, W
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 41 (06) : 636 - 644
  • [88] Tolterodine once-daily: Superior efficacy and tolerability in the treatment of the overactive bladder
    Van Kerrebroeck, P
    Kreder, K
    Jonas, U
    Zinner, N
    Wein, AN
    [J]. UROLOGY, 2001, 57 (03) : 414 - 421
  • [89] WANG P, 1995, J PHARMACOL EXP THER, V273, P959
  • [90] WEIN A, 2002, CAMPBELLS UROLOGY, V2
12345678910